When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Live Science on MSN9d
E. coli in the gut may fuel a 'chain reaction' leading to Parkinson's, early study suggestsTwo recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
News Medical on MSN2d
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback